Expression of neurogenic bHLH genes in primitive neuroectodermal tumors
US5795723A · kind A · utility
31Cited by
4References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 7, 1997 |
| Grant date | Aug 18, 1998 |
| Priority date | — |
| Expiry date | Aug 7, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/112
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are methods of classifying and prognosticating human neuroectodermal tumors by analyzing a sample of the tumor to determine whether various bHLH proteins are detectably expressed in the sample. In the methods disclosed herein, expression of the bHLH genes is assessed by measuring transcripts or proteins expressed from the genes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.